Home  >  Products  >  DMGDH (dimethylglycine dehydrogenase ) Blocking Peptide (the C terminal of DMGDH)(100ug)
DMGDH (dimethylglycine dehydrogenase ) Blocking Peptide (the C terminal of DMGDH)(100ug)

DMGDH (dimethylglycine dehydrogenase ) Blocking Peptide (the C terminal of DMGDH)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DMGDH Antibody (ARP64603_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64603
Size: 100ug
Weight: 91kDa
Gene: 29958
Format: Lyophilized powder
Target: This gene encodes an enzyme involved in the catabolism of choline, catalyzing the oxidative demethylation of dimethylglycine to form sarcosine. The enzyme is found as a monomer in the mitochondrial matrix, and uses flavin adenine dinucleotide and folate as cofactors. Mutation in this gene causes dimethylglycine dehydrogenase deficiency, characterized by a fishlike body odor, chronic muscle fatigue, and elevated levels of the muscle form of creatine kinase in serum.
Alternative names: DMGDHD; ME2GLYDH
See Full Product Listings >